Cargando…
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862828/ https://www.ncbi.nlm.nih.gov/pubmed/29563490 http://dx.doi.org/10.1038/s41408-018-0070-y |
_version_ | 1783308289809842176 |
---|---|
author | Krakowsky, Rosanna H. E. Wurm, Alexander A. Gerloff, Dennis Katzerke, Christiane Bräuer-Hartmann, Daniela Hartmann, Jens-Uwe Wilke, Franziska Thiede, Christian Müller-Tidow, Carsten Niederwieser, Dietger Behre, Gerhard |
author_facet | Krakowsky, Rosanna H. E. Wurm, Alexander A. Gerloff, Dennis Katzerke, Christiane Bräuer-Hartmann, Daniela Hartmann, Jens-Uwe Wilke, Franziska Thiede, Christian Müller-Tidow, Carsten Niederwieser, Dietger Behre, Gerhard |
author_sort | Krakowsky, Rosanna H. E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5862828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58628282018-03-22 miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia Krakowsky, Rosanna H. E. Wurm, Alexander A. Gerloff, Dennis Katzerke, Christiane Bräuer-Hartmann, Daniela Hartmann, Jens-Uwe Wilke, Franziska Thiede, Christian Müller-Tidow, Carsten Niederwieser, Dietger Behre, Gerhard Blood Cancer J Correspondence Nature Publishing Group UK 2018-03-21 /pmc/articles/PMC5862828/ /pubmed/29563490 http://dx.doi.org/10.1038/s41408-018-0070-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Krakowsky, Rosanna H. E. Wurm, Alexander A. Gerloff, Dennis Katzerke, Christiane Bräuer-Hartmann, Daniela Hartmann, Jens-Uwe Wilke, Franziska Thiede, Christian Müller-Tidow, Carsten Niederwieser, Dietger Behre, Gerhard miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia |
title | miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia |
title_full | miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia |
title_fullStr | miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia |
title_full_unstemmed | miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia |
title_short | miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia |
title_sort | mir-451a abrogates treatment resistance in flt3-itd-positive acute myeloid leukemia |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862828/ https://www.ncbi.nlm.nih.gov/pubmed/29563490 http://dx.doi.org/10.1038/s41408-018-0070-y |
work_keys_str_mv | AT krakowskyrosannahe mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT wurmalexandera mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT gerloffdennis mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT katzerkechristiane mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT brauerhartmanndaniela mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT hartmannjensuwe mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT wilkefranziska mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT thiedechristian mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT mullertidowcarsten mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT niederwieserdietger mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia AT behregerhard mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia |